Gabelli Funds LLC Cuts Position in Integer Holdings Corporation $ITGR

Gabelli Funds LLC trimmed its position in shares of Integer Holdings Corporation (NYSE:ITGR) by 26.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,450 shares of the medical equipment provider’s stock after selling 15,250 shares during the period. Gabelli Funds LLC’s holdings in Integer were worth $3,824,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of ITGR. Salomon & Ludwin LLC grew its stake in shares of Integer by 46.8% in the fourth quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 118 shares in the last quarter. TD Private Client Wealth LLC raised its holdings in shares of Integer by 1,037.5% in the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 415 shares during the period. Parkside Financial Bank & Trust lifted its stake in Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 267 shares in the last quarter. Arax Advisory Partners lifted its stake in Integer by 2,489.5% during the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 473 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its holdings in Integer by 193.2% during the 4th quarter. Farther Finance Advisors LLC now owns 519 shares of the medical equipment provider’s stock valued at $41,000 after acquiring an additional 342 shares during the period. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Stock Performance

Shares of ITGR opened at $100.32 on Wednesday. The stock has a 50-day simple moving average of $92.86 and a 200-day simple moving average of $88.49. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. The stock has a market capitalization of $3.41 billion, a PE ratio of 25.02, a PEG ratio of 2.37 and a beta of 0.64. Integer Holdings Corporation has a 1 year low of $62.00 and a 1 year high of $111.99.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). Integer had a return on equity of 12.83% and a net margin of 7.64%.The company had revenue of $439.58 million for the quarter, compared to analyst estimates of $426.48 million. During the same period in the prior year, the firm posted $1.31 earnings per share. The business’s quarterly revenue was up .5% compared to the same quarter last year. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, analysts predict that Integer Holdings Corporation will post 6.04 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ITGR has been the subject of several research reports. Piper Sandler reaffirmed an “overweight” rating and issued a $97.00 target price (up from $87.00) on shares of Integer in a research report on Friday, May 1st. Zacks Research raised shares of Integer from a “strong sell” rating to a “hold” rating in a research report on Monday, July 20th. Freedom Capital raised shares of Integer to a “strong-buy” rating in a research note on Wednesday, July 22nd. KeyCorp restated an “overweight” rating and issued a $104.00 price objective on shares of Integer in a report on Tuesday, July 21st. Finally, Truist Financial upped their target price on shares of Integer from $97.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, July 16th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.00.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.